BLCM - Bellicum Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Current Assets
Cash And Cash Equivalents43,69538,83933,14070,241
Short Term Investments49,30460,05770,63223,820
Net Receivables909320334440
Inventory----
Other Current Assets----
Total Current Assets95,295101,650105,61096,890
Long Term Investments-1,368-56,304
Property, plant and equipment20,87825,94216,5046,882
Goodwill----
Intangible Assets----
Accumulated Amortization----
Other Assets5,3286,5689,923330
Deferred Long Term Asset Charges----
Total Assets121,501135,528132,037160,406
Current Liabilities
Accounts Payable3,7743,2873,6232,106
Short/Current Long Term Debt--1,787-
Other Current Liabilities6,4574,7736,1492,991
Total Current Liabilities15,80412,15615,1137,445
Long Term Debt35,83234,94618,436-
Other Liabilities1,2963,6471,773826
Deferred Long Term Liability Charges----
Minority Interest----
Negative Goodwill----
Total Liabilities53,02350,88035,4638,389
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock442340278276
Retained Earnings-420,548-322,512-230,733-161,492
Treasury Stock-5,200-5,102-5,039-5,358
Capital Surplus493,784411,922332,068318,591
Other Stockholder Equity-144-4617-302
Total stockholders' equity68,47884,64896,574152,017
Net Tangible Assets68,47884,64896,574152,017